NEPHROS, INC. Notes and Loans Payable, Current
NEPHROS, INC. (NEPH) had Notes and Loans Payable, Current of $340.00 thousand as of 2020-09-30, per its 10-Q filed 2020-11-05.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt, Current Maturities › Notes and Loans Payable, Current
us-gaap:NotesAndLoansPayableCurrent · last filed 2020-11-05
- 2020-09-30: Notes and Loans Payable, Current $340.00K.
- 2020-06-30: Notes and Loans Payable, Current $278.00K.
| Period end | Notes and Loans Payable, Current |
|---|---|
| 2020-09-30 | $340.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $278.00K 10-Q · filed 2020-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |